Clinical Trial

A Trial of HRS-5817 in Obese Participants

Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess safety, PK, Pharmacodynamic and immunogenicity profile of a single dose of HRS-5817 in obese participants
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-13
Trial Details
NCT Number NCT07238647
Lead Sponsor Atridia Pty Ltd.
Conditions Obesity
Enrollment 40 participants
Start Date 2026-01-05
Primary Completion 2027-01-30 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-12